Complete Response to Immunotherapy in Patients With Hepatocellular Carcinoma.
Complete Response to Immunotherapy in Patients With Hepatocellular Carcinoma. JAMA Netw Open. 2025 Feb 03; 8(2):e2461735.
PMID: 39998829
Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product.
Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product. Nat Commun. 2025 01 02; 16(1):32.
PMID: 39746954
How to Predict Recurrence After Resection of Hepatocellular Carcinoma.
How to Predict Recurrence After Resection of Hepatocellular Carcinoma. Anticancer Res. 2025 Jan; 45(1):189-199.
PMID: 39740812
HCC spatial transcriptomic profiling reveals significant and potentially targetable cancer-endothelial interactions.
HCC spatial transcriptomic profiling reveals significant and potentially targetable cancer-endothelial interactions. Hepatol Commun. 2024 10 01; 8(10).
PMID: 39330965
Targeted therapies in hepatocellular carcinoma: past, present, and future.
Targeted therapies in hepatocellular carcinoma: past, present, and future. Front Oncol. 2024; 14:1432423.
PMID: 39267840
Spatially resolved immune drivers of HBV-associated HCC relapse.
Spatially resolved immune drivers of HBV-associated HCC relapse. Hepatology. 2025 May 01; 81(5):1394-1396.
PMID: 39106201
Hypofractionated Radiotherapy-Related Lymphopenia Is Associated With Worse Survival in Unresectable Intrahepatic Cholangiocarcinoma.
Hypofractionated Radiotherapy-Related Lymphopenia Is Associated With Worse Survival in Unresectable Intrahepatic Cholangiocarcinoma. Am J Clin Oncol. 2024 Aug 01; 47(8):373-382.
PMID: 38767086
Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product.
Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product. bioRxiv. 2024 Mar 14.
PMID: 38559183
Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker.
Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker. Cancer Discov. 2023 12 12; 13(12):2532-2547.
PMID: 37698949
Dysregulated Repeat Element Viral-like Immune Response in Hepatocellular Carcinoma.
Dysregulated Repeat Element Viral-like Immune Response in Hepatocellular Carcinoma. bioRxiv. 2023 Dec 05.
PMID: 38105940